This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
ChartMaxx, the enterprise content management (ECM) solution from Quest Diagnostics (NYSE:DGX), has achieved 2014 Edition Modular EHR*...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that its ChartMaxx® enterprise...
Approximately one in two patients with atrial fibrillation (Afib) do not optimally reduce their risk of stroke or bleeding when treated with the most...
A final rule issued today by the U.S. Department of Health and Human Services (HHS) giving Americans increased access to their personal health...
Fourth quarter adjusted diluted EPS from continuing operations of $1.03, 2% above prior year Fourth quarter reported diluted EPS from continuing...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has entered into a definitive...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report fourth quarter and full...
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors has elected...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and the University of California, San...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today updated its estimates for full-year 2013 revenues...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that BRCAvantage™, a service-rich oncology...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at...
Drug use among American workers declined dramatically over the past 25 years, although the rate of positive test results for certain drugs, including...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at...
Adjusted diluted EPS from continuing operations of $1.02, vs. $1.15 in 2012 Reported diluted EPS from continuing operations of $2.66, vs. $0.98 in 2012...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of BRCAvantage™,...
According to the results of a recent Quest Diagnostics (NYSE: DGX) survey, seventy-two percent (72 percent) of American women age 18 and older have...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today provided a preview of revenues and earnings per...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has acquired...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, has again been named to the Dow Jones Sustainability...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report third quarter 2013 results on
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that on September 30, 2013...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Care360 cloud-based...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of a new lab-developed...
Students at Harvard, Massachusetts Institute of Technology and Brown University, Massachusetts Asian & Pacific Islanders (MAP) for Health and local employee...
Quest Diagnostics (NYSE: DGX) and the New York Giants are teaming up to find new ways to use laboratory diagnostic information services to...
Adjusted diluted EPS from continuing operations of $1.06, vs. $1.15 in 2012 Reported diluted EPS from continuing operations of $0.99, vs. $1.09 in 2012...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has...
Quest Diagnostics Incorporated (NYSE: DGX) today announced that Mark J. Guinan will join the company on July 29 as its next Senior Vice President...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced a collaboration with the U.S. Centers...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter 2013...
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, today announced an agreement with AT&T* to provide the...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that Steve Rusckowski, President...
Quest Diagnostics (NYSE: DGX), the world's leading diagnostic information services company, and Hologic, Inc. (Hologic) (NASDAQ:...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that Steve Rusckowski, President...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has acquired the toxicology and...
Decades of declines in LDL cholesterol blood levels, a key marker of death risk from heart disease, abruptly ended in 2008, and may have stalled since,...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at...
Adjusted diluted EPS from continuing operations of $0.89, vs. $1.05 in 2012 Reported diluted EPS from continuing operations of $0.72, vs. $0.97 in...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that it has entered...
Quest Diagnostics (NYSE:DGX), the world's leading provider of diagnostic information services, announced today that Jim Davis, a former vice...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed the sale of its...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of two new blood tests...